Exozymes EXOZ Growth Metrics (2023-2026)

NASDAQ EXOZ
$4.00 -0.12 (-2.91%)
As of: Oct 21, 2026 · 3:56 PM EDT
Reported Financials

Exozymes Quarterly Growth Metrics

Periods 10 quarters
Latest Jun 2026

Exozymes reported revenue growth of -97.60% and asset growth of -17.51% for the quarter ended Jun 2026. These growth metrics cover 10 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Growth Ratios
Assets Growth (1y) 266.29%116.80%-54.19%-17.51%
Assets (QoQ) 266.10%-11.57%-16.04%-20.23%-22.64%
Capital Expenditures Growth (1y)Capex Growth (1y) 91.73%-79.14%35.81%-64.36%
Capital Expenditures (QoQ)Capex (QoQ) 35.60%-74.98%-85.24%62.90%-73.68%463.40%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 14,508.25%2,079.53%-68.73%-19.08%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 4,054.71%-12.43%-17.92%-27.01%-40.39%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -91.73%78.20%17.09%-143.13%64.36%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -29.78%73.86%182.87%-781.88%85.24%0.55%56.90%-463.50%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -628.67%-503.11%39.40%-242.87%65.42%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 135.90%-1,002.49%78.66%-953.97%80.14%-35.68%-20.72%-6.31%
EBITDA Margin Growth (1y) -0.07M
EBITDA Margin (QoQ) -0.07M-0.12M-0.09M0.22M
EBIT Growth (1y) -311.32%-101.34%-93.44%-91.78%-56.49%-35.91%-15.93%
EBIT Margin Growth (1y) -0.07M-15.72M
EBIT Margin (QoQ) -0.08M-0.13M-0.09M0.22M
EBIT (QoQ) -151.39%-2.38%-31.75%-21.31%-23.06%1.64%-30.62%1.01%-6.87%
EBT Growth (1y) -218.17%-74.02%-84.09%-73.76%-38.07%-50.17%-21.96%
EBT Margin Growth (1y) -0.09M-15.34M
EBT Margin (QoQ) -0.08M-0.11M-0.08M0.18M
EBT (QoQ) -102.90%4.53%-34.70%-21.94%-10.97%-1.00%-27.14%3.11%-20.69%
EPS (Basic) Growth (1y) -218.05%-59.15%-37.50%-29.45%-2.93%-13.24%-17.98%
EPS (Basic) (QoQ) -111.02%8.20%-34.89%-21.72%-5.59%20.69%-27.00%3.22%-16.17%
EPS (Diluted) Growth (1y) -218.05%-59.15%-37.50%-29.45%-2.93%-13.24%-17.98%
EPS (Diluted) (QoQ) -111.02%8.20%-34.89%-21.72%-5.59%20.69%-27.00%3.22%-16.17%
FCF Margin Growth (1y) 0.23M
FCF Margin (QoQ) 0.27M-0.08M-0.11M0.16M
Free Cash Flow Growth (1y)FCF Growth (1y) -562.69%-979.65%38.31%-245.33%65.38%
Free Cash Flow (QoQ)FCF (QoQ) 114.83%-2,045.02%78.97%-992.83%80.32%-36.41%-17.72%-9.56%
Net Cash Flow Growth (1y)NCF Growth (1y) 2,424.72%-2,655.56%-3,630.08%-2,570.43%-121.71%
Net Cash Flow (QoQ)NCF (QoQ) 111.58%-5.97%70.32%12,430.88%-112.73%-29.89%-19.19%-10.12%
Net Income Growth (1y) -218.17%-67.12%-84.09%-73.48%-38.07%-44.61%-21.96%
Net Income (QoQ) -111.02%8.20%-34.91%-21.74%-10.84%-1.11%-27.14%3.11%-16.09%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -218.17%-67.12%-84.09%-73.48%-38.07%-44.61%-21.96%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -111.02%8.20%-34.91%-21.74%-10.84%-1.11%-27.14%3.11%-16.09%
Net Margin Growth (1y) -0.08M-15.34M
Net Margin (QoQ) -0.08M-0.11M-0.08M0.19M
Operating Income Growth (1y)Op. Inc Growth (1y) -311.32%-101.34%-93.44%-91.78%-56.49%-35.91%-15.93%
Operating Income (QoQ)Op. Inc (QoQ) -151.39%-2.38%-31.75%-21.31%-23.06%1.64%-30.62%1.01%-6.87%
Operating Margin Growth (1y) -0.07M-15.72M
Operating Margin (QoQ) -0.08M-0.13M-0.09M0.22M
Profit After Tax Growth (1y)PAT Growth (1y) -218.17%-74.02%-84.09%-73.48%-38.07%-50.17%-21.96%
Profit After Tax (QoQ)PAT (QoQ) -102.90%4.53%-34.91%-21.74%-10.97%-1.00%-27.14%3.11%-20.69%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 17.13%3.16%-13.38%-18.31%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 19.31%-4.47%-2.57%-7.10%0.18%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -0.01M-0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -0.01M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M0.00M0.00M-0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 0.00M-0.02M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.01M0.00M0.00M-0.01M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -0.07M-15.72M
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.08M-0.13M-0.09M0.22M
Revenue Growth (1y) 21,820.14%357.06%232.56%-13.15%-97.60%
Revenue (QoQ) -49.91%440.54%-37.97%-18.82%-22.69%123.10%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 417.05%196.25%122.17%62.88%34.18%113.65%69.42%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 74.53%33.35%143.87%-8.90%0.00%0.00%78.79%-24.95%59.23%

Exozymes Growth Metrics API

Pull Exozymes's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EXOZ&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY